Organizing Committee Members
Organizing Committee Members of International Conference on Cancer Research & Treatment 2019
Our Organizing Committee members are the pride of our conferences. These are the members who will make the event more memorable and happening. They will not just share their intellectual with us, but will also help us understand some of the most key areas of the topic they will be discussing with us through this conference.
It shall be a great honour to have such influential members on board to help us through the moments of this era.
Full Professor of Molecular Biology, University of Catanzaro “Magna Graecia,” since 1995. He has over 25 years of research management experience. In particular, his experience at Merck Sharp and Dohme research centre IRBM P. Angeletti in Pomezia (Rome) from 1991-2009 included responsibilities for several early drug discovery programs (target identification to phase I clinical trials), membership of several decision-making committees, and Site Head and Managing Director for 200 employees (2006-2009).
In November 2009, he co-founded Takis s.r.l., a spin-off of the IRBM P. Angeletti, with the main focus on research and development in Oncology. In March 2012, he was appointed Scientific Director of IRCSS Istituto Nazionale Tumori, Senatore “G. Pascale” Napoli. He has over 200 publications in the areas of cancer stem cell therapy, cancer vaccines, somatic gene therapy, structure and function of cytokines (e.g. IL6), and transcriptional control of acute phase response.
He has acquired significant experience in the field of Technology Transfer as evidenced by his presence as Co-inventor in more than 25 international patents. Referee and member of the editorial board of numerous international scientific journals, and editor of a Molecular Biology textbook for university students.
Rony Seger is a professor in the Department of Biological Regulation, the Weizmann Institute of Science, Rehovot, Israel. He completed his doctorate at the Weizmann Institute at 1990 and moved to postdoc training with the late Prof. Krebs at Washington University, USA. At 1994 he re-joined the Weizmann Institute as a group leader.
Over the years Dr. Seger contributed significantly to the field of signal transduction, and recently to the stimulated nuclear translocation of MAPKs. Dr. Seger published more than 200 papers, supervised more than 100 students or postdoctoral fellows, and received several prizes including the Teva research prize.
Dr. Jurgen Lademann serves as Director of the Center of Experimental and Applied Cutaneous Physiology (CEACP), at the Department of Dermatology, Venerology and Allergology of Charite Berlin. Dr. Lademann is a leading expert on the non-invasive measurement of biomarkers in human skin.
He is editor of the international journal "Skin Pharmacology and Applied Skin Physiology," and board member of the German Federal Institute of Risk Assessment, Berlin, Germany. He is an internationally recognized researcher who is focused on the interface between dermatology, pharmacology and biophysics.
Originally a physicist, he has been head of the department of “Experimental and Applied Physiology of the Skin” at the Hospital for Dermatology, Venereology and Allergology, at the Charité – Universitätsmedizin Berlin since 1996. He was appointed professor for dermatology in 2001.
Narayan S. Hosmane was born in Gokarn, Southern India, and is a B.S. and MS graduate of Karnatak University, India. He obtained a Ph.D. in Inorganic Chemistry in 1974 from the University of Edinburgh. After postdoctoral research in U.K. and in the USA (UVa), he joined Virginia Tech and then moved to SMU in 1982, where he became Professor of Chemistry in 1989. In 1998 he moved to Northern Illinois University as a Distinguished Research and Board of Trustees Professor.
His international awards include but are not limited to the Alexander von Humboldt Foundation’s Senior U.S. Scientist Award twice; the BUSA Award for Distinguished Achievements in Boron Science; the Gauss Professorship of the Göttingen Academy of Sciences, Visiting Professor of the Chinese Academy of Sciences and Foreign Member of the Russian Academy of Natural Sciences. He has published over 325 papers in leading scientific journals and an author of five books on boron science and cancer therapies.
Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne.
His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.
Research interest: Bionanotech.
Dr Lazar Mathew is an Indian scientist and former Director of Defence Research and Development Organisation and Institute of Nuclear Medicine & Allied Sciences. He has also been Director of Defence Bioengineering and Electromedical Laboratory. In 1994, he was honoured with the DRDO Scientist of the Year Award.
Mathew is serving as an advisor of Medical Sciences and Engineering and Technology at PSG Institute of Medical Sciences & Research, Coimbatore. He has served as the Dean of the School of Biotechnology and Chemical and Biomedical Engineering at VIT University, Vellore.